Cardiometabolic comorbidity in antipsychotic treated patients: need for systematic evaluation and treatment

The Epidemiology of Excess Mortality in People with Mental Illness

(2017) David Lawrence et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level

(2015) MARC DE HERT et al.   World Psychiatry

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

(2015) MARC DE HERT et al.   World Psychiatry

Life expectancy and cardiovascular mortality in persons with schizophrenia

(2012) Thomas M. Laursen et al.   CURRENT OPINION IN PSYCHIATRY

Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: A systematic review

(2011) Nick Verhaeghe et al.   International Journal of Behavioral Nutrition and Physical Activity

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices

(2011) A. J. Mitchell et al.   PSYCHOLOGICAL MEDICINE

Life expectancy among persons with schizophrenia or bipolar affective disorder

(2011) Thomas Munk Laursen   SCHIZOPHRENIA RESEARCH

The High Prevalence of Poor Physical Health and Unhealthy Lifestyle Behaviours in Individuals with Severe Mental Illness

(2011) David Scott et al.   Issues in Mental Health Nursing

Differential metabolic effects of distinct statins

(2010) Kwang Kon Koh et al.   ATHEROSCLEROSIS

Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia

(2010) Davy Vancampfort et al.   PSYCHIATRY RESEARCH

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

(2009) S. M. Stahl et al.   ACTA PSYCHIATRICA SCANDINAVICA

Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis

(2009) William L. Baker et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

The incidence of metabolic syndrome and its reversal in a cohort of schizophrenic patients followed for one year

(2009) S.G. Schorr et al.   JOURNAL OF PSYCHIATRIC RESEARCH

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

Diabetes and schizophrenia – effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia

(2008) S. Saddichha et al.   ACTA PSYCHIATRICA SCANDINAVICA

Quality of Care for Cardiovascular Disease-related Conditions in Patients with and without Mental Disorders

(2008) Amy M. Kilbourne et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Body composition in psychotic disorders: a general population survey

(2008) S. E. Saarni et al.   PSYCHOLOGICAL MEDICINE

IS IT APPROPRIATE TO USE CARDIOVASCULARRISK SCORES IN PATIENTS WITH PSYCHOTIC DISORDERS?

(2008) Katja Taxis et al.   SCHIZOPHRENIA RESEARCH